FAQ

How long has 3M been delivering IDD systems?
3M has been a leader in inhalation research and development for more than 50 years. Our proven track record includes development of the first metered-dose inhaler (MDI) in 1956. Significant developments since that time have included the launch of the Autohaler™ in 1987, the introduction of the world's first CFC-free MDI in 1995 and the patient-friendly 3M™ Integrated Dose by Dose Counter in 2007. The 3M culture of innovation helps ensure your formulation’s technical success.

How can I determine if the inhalation route will deliver my drug?
3M utilizes a variety of techniques to evaluate the compatibility of your drug with our systems. To help determine if inhalation is appropriate for your molecule, we will perform a pre-feasibility assessment and/or conduct feasibility experiments as determined by your needs. As an added value, we offer a free paper feasibility for the first stage of assessment. Contact us or visit our partnering page for more information.

What are the advantages of choosing 3M?
3M Drug Delivery Systems offers more than 50 years of inhalation experience and proven success in technology, product development and manufacturing. Coupled with our global regulatory expertise, we can offer a partnership that ensures a smooth process from start to finish and help you bring your products to market more quickly. Working with us, you get the speed to market that’s critical to the success of your new application.

If you have additional questions or would like more information about specific 3M Drug Delivery Systems or services, please contact us.